Biotech

Farshad Guirakhoo, Ph.D., Joins GeoVax as Senior Vice President, Research and Development

ATLANTA, GA: Scientific Leadership Team Strengthened ...

MedMira Receives FDA Approval for the Reveal(R) G4 Rapid HIV-1 Antibody Test

HALIFAX, NOVA SCOTIA: Expands Proven Rapid Vertical Flow Technology(TM) Platform to Next Generation Whole Blood Rapid HIV Test and New Market Sectors in the U.S. ...

Medifocus Inc. Announces Exclusive Agreement With Major Academic Medical Center to License Technology to Develop Heat-Activated and Tumor-Targeted Immunotherapy and Gene Therapy

COLUMBIA, MD and TORONTO, ON: ...

M Pharmaceutical, Inc. Engages Roy M. Kulick, MD as Clinical Development Advisor

VANCOUVER, BRITISH COLUMBIA: ...

Atossa Genetics Hires Janet Rose Rea, M.S.P.H. as VP Regulatory Affairs and Quality

SEATTLE, WA: ...

SuperSonic Imagine Announces the Recognition of ShearWave(TM) Elastography''s Exceptional Clinical Value in Mettler Institute''s Award Winning Presentation

AIX-EN-PROVENCE, FRANCE: Mettler Institute Received Prestigious Award at the 2015 International Fascia Research Congress ...

Threshold Pharmaceuticals Receives Two U.S. Patents for Tarloxotinib Bromide

SOUTH SAN FRANCISCO, CA: ...

ProMetic''s PBI-4050 Granted Orphan Drug Designation for the Treatment of Idiopathic Pulmonary Fibrosis in Europe

LAVAL, QUEBEC: ...

Data From New Retrospective Studies of VIBATIV(R) (Telavancin) Demonstrate Positive Clinical Outcomes for Patients With Difficult-to-Treat, Gram-Positive Infections, Including MRSA

DUBLIN, IRELAND: Positive Findings Support Company's Current Development and Regulatory Efforts for VIBATIV ...

Sermonix to Present Scientific Poster Comparing Investigational Drug Lasofoxifene to Raloxifene at American Society for Bone and Mineral Research Annual Meeting

COLUMBUS, OH: ...